Efficacy of pneumococcal vaccination in patients with multiple myeloma receiving novel agents: Results of a prospective clinical study

Efficacy of pneumococcal vaccination in patients with multiple myeloma receiving novel agents: Results of a prospective clinical study

Bibliographic Details
Main Authors:	I. Stoma, I. Karpov, I. Iskrov, I. Lendina, A. Trubkina, A. Uss
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220319482

Similar Items

Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma
by: I. O. Stoma
Published: (2021-01-01)

Response to pneumococcal vaccination in multiple myeloma
by: Loïc Renaud, et al.
Published: (2019-07-01)

DECOLONIZATION OF INTESTINAL CARRIAGE OF MDR/XDR GRAM-NEGATIVE BACTERIA WITH ORAL COLISTIN IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: RESULTS OF A RANDOMIZED CONTROLLED TRIAL
by: Igor Stoma, et al.
Published: (2018-05-01)

Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia
by: Igor Stoma, et al.
Published: (2019-02-01)

Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response
by: Michael A. Thompson, et al.
Published: (2017-08-01)

Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens
by: Igor Stoma, et al.
Published: (2017-03-01)

Pneumococcal Vaccines: Challenges and Prospects
by: Paul Licciardi, et al.
Published: (2019-02-01)

Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

Efficacy of 13-valent pneumococcal conjugate vaccine in healthcare workers
by: L A Shpagina, et al.
Published: (2018-11-01)

Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children
by: S. M. Kharit, et al.
Published: (2016-12-01)

The Results of a Three-Year Pneumococcal Vaccination of Children in Russia
by: Nikolay I. Briko, et al.
Published: (2018-10-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Vaccination against pneumococcal infections in adults
by: Kozlov R.S., et al.
Published: (2018-02-01)

ANALYSIS OF PNEUMOCOCCAL VACCINATION EFFICACY AND SAFETY IN CHILDREN WITH VARIOUS DISABILITIES OF HEALTH
by: A. G. Gaivoronskaya, et al.
Published: (2012-04-01)

Evaluation of pneumococcal conjugate vaccine (Prevenar®) inpatients with myeloma and chronic lymphocytic leukaemia
by: Greenfield, Hayley Maria
Published: (2009)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

SEROTYPE-INDEPENDENT VACCINES AGAINST PNEUMOCOCCAL INFECTION
by: I. B. Semenova, et al.
Published: (2016-08-01)

Constrained Optimization for Pneumococcal Vaccination in Brazil
by: Gomez, J.A, et al.
Published: (2021)

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
by: Lipsky Benjamin A, et al.
Published: (2000-09-01)

Vaccination against pneumococcal infection in adults from risk groups
by: N. I. Briko, et al.
Published: (2020-06-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome
by: Shamitha Thishakya Goonewardene, et al.
Published: (2019-08-01)

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines
by: Hyunju Lee, et al.
Published: (2014-02-01)

RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2009-12-01)

RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2009-12-01)

Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review
by: Ekaterina I. Alekseeva, et al.
Published: (2019-06-01)

To Evaluate the Efficacy of a Potential Pneumococcal Vaccine Candidate, PrtA, Preventing Pneumococcal Colonization
by: Jian-Ru Chen, et al.
Published: (2013)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents.
by: Koichi Kamei, et al.
Published: (2020-01-01)

Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents
by: Koichi Kamei, et al.
Published: (2020-01-01)

Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia
by: Esam I Azhar, et al.
Published: (2016-01-01)

Efficacy of usage of pneumococcal 7-valent vaccine in prophylaxis of pneumococcal infection in Novosibirsk children from risk groups
by: O. A. Beletskaya, et al.
Published: (2013-03-01)

MODERN POSSIBILITIES AND EFFECTIVENESS OF VACCINE PREVENTION OF PNEUMOCOCCAL INFECTION IN CHILDREN
by: A. L. Zaplatnikov, et al.
Published: (2016-12-01)

Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
by: Stubbs Liz, et al.
Published: (2009-08-01)

EVALUATION OF THE PROGNOSTIC EPIDEMIOLOGICAL AND ECONOMIC EFFICACY OF VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN MEN OF WORKING AGE WITH VARIOUS CHRONIC DISEASES
by: N. I. Briko, et al.
Published: (2018-02-01)

Immunogenicity and Efficacy of Pneumococcal Conjugate Vaccine (Prevenar13®) in Preventing Acquisition of Carriage of Pneumococcal Vaccine Serotypes in Tanzanian Children With HIV/AIDS
by: Geofrey Makenga, et al.
Published: (2021-06-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

EFFICIENCY OF PNEUMOCOCCAL VACCINE IN CHILDREN WITH DIFFERENT PATTERNS OF TUBERCULOSIS INFECTION
by: I. F. Dovgalyuk, et al.
Published: (2017-01-01)